As a complex network of cells and proteins throughout the body, the immune system helps our body to defend itself against infections.

In some cases, the immune system can be over-active, resulting in an excessive immune response against substances in the environment (such as with allergic reactions) or a response to normal components of the body (such as in autoimmune diseases). 

Researchers at TRI are studying the processes behind immunological disorders such as autoimmune disorders and bone and joint disorders, and ways we can train the immune system to target cancer cells via immunotherapies.

Image: Lymphocyte illustration (Big Stock Photo: urfingus ID123040430)

Key Researchers
Michael McGuckin
Matthew Arthur Brown
Stephen Robert Mattarollo
Tim Wells
Allison Pettit
Antje Blumenthal
David Evans
Graham Robert Leggatt
Kristen Radford
Ranjeny Thomas
Raymond John Steptoe
Show More ...
Click a program below to learn more
Autoimmune and Autoinflammatory Diseases
Bone and Joint Diseases
Inflammatory Bowel Disease
Vaccine response linked to metabolic hormone TRI-based researchers from The University of Queensland Diamantina Institute have discovered that reduced levels of the metabolic hormone, leptin, is...Read more
Mater researcher identifies links in high cholesterol and protective infection outcomes High cholesterol is associated with an increased risk of heart disease, but TRI-based Mater Research scientists...Read more
Clinician-researcher focuses on patients with rare lymphoma Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at the Translational...Read more
Aussie invention propelling needle-free vaccine delivery The Translational Research Institute is home to Australian biotech, Vaxxas, which is set to both disrupt and revolutionise vaccine delivery...Read more
Awakening the immune system to fight diseases Scientists at The Translational Research Institute (TRI) are harnessing the body’s front-line immune cells to fight cancer, with potential new...Read more
New autoimmune disease and cancer therapeutics edging closer to reality for patients A career dedicated to rheumatoid arthritis has led Professor Ranjeny Thomas AM to the development of a potential...Read more
CSL signs deal for new autoimmune disease therapeutic Biotech leader, CSL has announced a partnership deal to develop and commercialise an autoimmune disease therapeutic developed by The University...Read more
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more
Largest microarray patch clinical vaccination study ever performed Immune response significantly higher, faster Vaccine shown to be stable for 12 months at temperatures as high as 40 o C Vaxxas...Read more
TRI-based researchers from The University of Queensland (UQ) were involved in discovering how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack...Read more